Synaptic Pruning in Schizophrenia: Does Minocycline Modulate Psychosocial Brain Development?

Bioessays. 2020 Sep;42(9):e2000046. doi: 10.1002/bies.202000046. Epub 2020 Jul 30.

Abstract

Recent studies suggest that the tetracycline antibiotic minocycline, or its cousins, hold therapeutic potential for affective and psychotic disorders. This is proposed on the basis of a direct effect on microglia-mediated frontocortical synaptic pruning (FSP) during adolescence, perhaps in genetically susceptible individuals harboring risk alleles in the complement component cascade that is involved in this normal process of CNS circuit refinement. In reviewing this field, it is argued that minocycline is actually probing and modulating a deeply evolved and intricate system wherein psychosocial stimuli sculpt the circuitry of the "social brain" underlying adult behavior and personality. Furthermore, this system can generate psychiatric morbidity that is not dependent on genetic variation. This view has important ramifications for understanding "pathologies" of human social behavior and cognition as well as providing long-sought potential mechanistic links between social experience and susceptibility to mental and physical disease.

Keywords: drugs and controlled; electronic health records; mental health; microglia; minocycline; schizophrenia; substances.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Brain
  • Humans
  • Minocycline* / pharmacology
  • Minocycline* / therapeutic use
  • Neuronal Plasticity
  • Personality
  • Schizophrenia* / drug therapy
  • Schizophrenia* / genetics

Substances

  • Minocycline